Cite Filings / KROS / 0001104659-25-100554

Feed Companies Filings Check

Sign in

SC TO-I

Tender Offer Statement by Issuer

Keros Therapeutics, Inc. Filed 2025-10-20 Acc 0001104659-25-100554

Documents 1

SC TO-I Tender Offer Statement by Issuer , tm2528628-1_sctoi.htm

Around this filing

2025-10-22 SCHEDULE 13G Statement of Beneficial Ownership
2025-10-20 SC TO-I Tender Offer Statement by Issuer
2025-10-17 4 10% owner sold 4,787,331 shares at $17.75 ($84,975,125)
2025-10-16 SCHEDULE 13D/A Beneficial Ownership Report
2025-10-15 SC TO-C Written Communication Relating to an Issuer
2025-10-15 4 10% owner sold 5,389,264 shares at $17.75 ($95,659,436)
2025-10-15 SCHEDULE 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading tm2528628-1_sctoi.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…